tarka 240 mg/2 mg
abbvie deutschland gmbh & co. kg - germania - combinatii (verapamilum+trandolaprilum) - compr. cu elib. prel. - 240mg/2mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
duodopa 20 mg/ml+5 mg/ml
fresenius kabi norge as - norvegia - combinatii (levodopum+carbidopum) - gel intestinal - 20mg/ml+5mg/ml - medicamente dopaminergice dopa si derivati
aluvia 100 mg + 25 mg comprimate filmate
abbvie biopharmaceuticals gmbh - lopinavirum + ritonavirum - comprimate filmate - 100 mg + 25 mg
darob 80 mg
abbvie deutschland gmbh&co. kg - germania - sotalolum - compr. - 80mg - medicamente betablocante betablocante neselective
rytmonorm 150 mg
abbvie deutschland gmbh&co. kg - germania - propafenonum - compr. film. - 150mg - antiaritmice clasa i si iii antiaritmice clasa ic
kaletra
abbvie deutschland gmbh co. kg - lopinavir, ritonavir - infecții cu hiv - antivirals for systemic use, protease inhibitors - kaletra este indicat în combinatie cu alte medicamente antiretrovirale pentru tratamentul de virusul imunodeficienţei umane (hiv-1) infectate adulţi, adolescenţi şi copii în vârstă de 14 de zile şi mai mari. alegerea de kaletra pentru a trata inhibitor de protează infectați cu hiv-1 pacienții ar trebui să se bazeze pe testarea rezistenței virale individuale și de istorie de tratament a pacienților.
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artrita, reumatoida - imunosupresoare - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
norvir
abbvie deutschland gmbh co. kg - ritonavir - infecții cu hiv - antivirale pentru uz sistemic - ritonavir este indicat în combinatie cu alte medicamente antiretrovirale pentru tratamentul pacienţilor infectaţi cu hiv-1 (adulţi şi copii de doi ani şi mai în vârstă).
zemplar 5 micrograme/ml
abbvie s.r.l. - italia - paricalcitolum - sol. inj. - 5micrograme/ml - preparate antihormoni paratiroidieni medicamente antihormoni paratiroidieni
moderiba 200 mg
abbvie limited - ribavirinum - compr. film. - 200mg - antivirale cu actiune directa nucleozide & nucleotide excl inhib. si reverstranscriptei